- Report
- September 2019
- 399 Pages
Global
From €1338EUR$1,375USD£1,146GBP
€2676EUR$2,750USD£2,292GBP
- Report
- October 2023
- 145 Pages
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- March 2023
- 185 Pages
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- March 2023
- 185 Pages
North America
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- July 2023
- 132 Pages
Global
From €924EUR$950USD£792GBP
- Book
- June 2020
- 198 Pages
- Report
- March 2020
- 103 Pages
Global
From €4378EUR$4,500USD£3,751GBP
- Report
- July 2023
- 140 Pages
Global
From €5837EUR$5,999USD£5,000GBP
Theranostics is a field of medicine that combines diagnostics and therapeutics to provide personalized treatments for patients. It is closely related to genomics, which is the study of an individual's genetic makeup. Theranostics uses genomic information to identify the best treatment for a patient, based on their unique genetic profile. This approach is becoming increasingly popular as it allows for more precise and effective treatments.
Theranostics is used in a variety of medical fields, including oncology, neurology, and cardiology. It is also being used to develop new treatments for rare diseases. By combining genomic data with other medical information, such as imaging and laboratory tests, doctors can better understand a patient's condition and develop more effective treatments.
Some companies in the Theranostics market include Illumina, Thermo Fisher Scientific, and Qiagen. These companies provide products and services related to genomics, such as DNA sequencing, gene expression analysis, and bioinformatics. They also offer products and services related to theranostics, such as biomarker discovery and drug development. Show Less Read more